INTERDISCIPLINARY RADIOBIOLOGY CLINICAL BRACHYTHERAPY PHYSICS RTT YOUNG
129
Programme and Exhibition Guide |
SCIENTIFIC PROGRAMME
MONDAY 8 MAY 2017
relative to low grade glioma and grade III glioma, emphasising the role of biology
and molecular biomarkers in selecting appropriate treatments and integrating
chemotherapy and radiotherapy at the best. Finally, the last speaker will present the
current concepts for “paediatric” brain tumours in adults, showing how there is a
clear need for specifically tailored concepts in adults.
Chair: U. Ricardi (Italy)
Co-chair: M. Chorvath (Slovakia)
08:45 > Radiotherapy for low grade glioma in adults in 2017. What’s crazy!
Speaker: S. Villà Freixa (Spain)
SP-0390
09:10 > What is the role of combined chemo-radiotherapy for grade III glioma
in adults?
Speaker: A. Chalmers (UK)
SP-0391
09:35 > ‘Paediatric’ brain tumours in adults
Speaker: C. Seidel (Germany)
SP-0392
SYMPOSIUM
MR guided radiotherapy: the new standard of care in 10 years time
08:45 - 10:00 | SCHUBERT
MRI with its superb soft tissue contrast and capacity for functional imaging is
increasingly being used for image-guided radiotherapy in a number of indications. In
10 years MRI may therefore be utilised for a wide range of radiotherapy techniques.
Pioneering studies have already provided evidence for improved clinical outcome
by use of MRI guided adaptive brachytherapy and technical innovations such as the
MRI-Linac will make on line MRI guided adaptive external beam radiotherapy a
clinical reality. With this symposium we aim to provide a comprehensive overview of
the challenges and opportunities that MRI guided external beam radiotherapy and
brachytherapy provide.
Chair: J.C. Lindegaard (Denmark)
Co-chair: B. Segedin (Slovenia)
08:45 > Clinical opportunities with MR guided external beam RT
Speaker: S. Mook (The Netherlands)
SP-0393
09:03 > MR guided brachytherapy - successes and potential future
developments
Speaker: P. Hoskin (UK)
SP-0394
09:21 > Challenges associated with MR guided radiotherapy
Speaker: D. Jaffray (Canada)
SP-0395